dopamine agonist

Term ID

CHEBI:51065

Synonyms

Agonista dopaminergico
Dopamine receptor agonist
Dopaminergic agonist

Definition

A drug that binds to and activates dopamine receptors.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: dopaminergic agent

dopaminergic agent Show first 5 Terms
has subtype: dopamine receptor D1 agonist

dopamine receptor D1 agonist Show first 5 Terms
inverse has_role: (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol hydrochloride 2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol 2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol maleate amantadine hydrochloride ... Show All 35 Terms

(1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol (1R,3S)-3-(adamantan-1-yl)-1-(aminomethyl)-3,4-dihydroisochromene-5,6-diol hydrochloride 2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol 2-{[(2E)-3-iodoprop-2-en-1-yl](propyl)amino}tetralin-7-ol maleate amantadine hydrochloride apomorphine azodopa bromocriptine cabergoline cariprazine cariprazine hydrochloride carmoxirole carmoxirole hydrochloride dihydroergotamine fenoldopam lisuride LY404039 lysergic acid diethylamide mesulergine metergoline N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide N-allyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol hydrobromide naxagolide naxagolide hydrochloride pergolide pergolide mesylate pramipexole pramipexole hydrochloride pramipexole hydrochloride anhydrous quinpirole ropinirole Show first 5 Terms

Phenotype

Phenotype resulting from dopamine agonist

Phenotype where environments contain dopamine agonist

Phenotype modified by environments containing dopamine agonist

Human Disease Model